ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

TTNP Titan Pharmaceuticals Inc

6.34
-0.1409 (-2.17%)
May 17 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 192k149k95k121k98k83k3k0
Operating Income -2.54M-2.44M-2.64M-2.61M-1.7M-1.59M-2.06M-1.93M
Pre Tax Income -2.54M-2.46M-2.64M-2.57M-1.68M-1.59M-338k-1.97M
Net Income -2.54M-2.46M-2.64M-2.57M-1.68M-1.59M-338k-1.97M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -2.54M-2.47M-2.66M-2.59M-1.7M-1.59M-327k-1.96M
EBITDA -2.49M-2.39M-2.6M-2.57M-1.65M-1.55M-2.03M-1.93M
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 15.07M215k6.62M3.61M4.84M1.53M557k184k
Operating Income 4.34M-14.5M-8.26M-16.84M-7.35M-9.35M-10.24M-7.28M
Pre Tax Income 5.14M-14.31M-9.02M-16.46M-7.41M-8.78M-10.21M-5.57M
Net Income 5.14M-14.31M-9.31M-16.46M-18.24M-8.78M-10.21M-5.57M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 0.235-0.656-0.684-0.284-2.355-0.834-0.653-0.336
EBIT 4.27M-14.56M-8.27M-16.6M-5.72M-8.78M-10.26M-5.57M
EBITDA 4.72M-14.09M-7.88M-16.6M-7.06M-9.13M-10.04M-7.17M